Home >

Over-the-Counter

Over-the-Counter (OTC) drugs are medicines that can be purchased without a prescription. Many large pharma companies also have a consumer health division, and this section will share relevant content in that area.

Articles

FDA panel says OTC decongestant ingredient doesn't work

The agency will now decide if it should revoke phenylephrine's GRASE status

Bankrupt Purdue Pharma to sell consumer health biz

A U.S. bankruptcy court will allow Purdue to sell Avrio Health for $397 million to a subsidiary of Arcadia Consumer Healthcare

After billions spent on litigation, J&J dumps talc powder

Johnson & Johnson has announced that the company's flagship and highly litigated talc-based JOHNSON’S Baby Powder will be discontinued globally in 2023.

Meet Haleon, GSK’s new consumer health unit

GlaxoSmithKline is forging ahead with plans for the proposed demerger of its Consumer Healthcare unit, unveiling a name for the new unit: Haleon

Unilever walks away from GSK Healthcare biz

Unilever officially walked away from its attempts to buy GlaxoSmithKline’s Consumer Healthcare business with the consumer goods giant announcing it would not raise its original...

News

GSK rejects $68B bid for Consumer Healthcare from Unilever

J&J announces major business restructuring

Lonza sells off specialty ingredients company to focus on drugs

FDA issues Benadryl warning amid TikTok challenge

Takeda to sell Japan consumer health unit to Blackstone

GSK recalls children's cough syrup due to packaging mistake

Stealing pharma's sunshine

How sunscreen is driving a resource and capacity shortage

GSK sells 15 OTC products to Stada

German generic drugmaker Stada said it has agreed to buy 15 consumer healthcare products from GlaxoSmithKline to further strengthen its prescription-free drugs business in Europe...

Sanofi considers sale, spin-off, joint venture of consumer healthcare unit

Sanofi is considering a joint venture, spin-off or outright sale of its consumer healthcare unit, according to Reuters sources.

GSK hires new chairman as it prepares for split

GlaxoSmithKline has hired a former finance chief from Novartis and AstraZeneca as its new non-executive chairman.

FDA hands Eton Pharma CRL for eye drops

Eton Pharmaceuticals announced that the U.S FDA provided Eton’s partner with a Complete Response Letter relating to the application for investigational eye drops.

Pharma's budding opportunity

Why the industry is forming bonds with CBD

Daiichi Sankyo denies OTC sale rumors

The Japanese media reported that Daiichi Sankyo was in talks with several companies to sell its over-the-counter drug unit, Daiichi Sankyo Healthcare, but the company has denied...

Teva, Procter & Gamble end OTC venture

Teva Pharmaceuticals has agreed with Procter & Gamble to terminate the PGT Healthcare partnership that they founded in 2011 to market OTC medicines.

GSK pulls bid for Pfizer OTC

GlaxoSmithKline has withdrawn from the auction to buy Pfizer’s consumer healthcare business — a sale that Pfizer had hoped would bring in as much as $20 billion.

Bayer recalls Alka-Seltzer due to packaging issues (again)

Bayer is voluntarily recalling Alka-Seltzer Plus packages that were sold in the U.S. at Walmart, CVS, Walgreens and Kroger after February 9, 2018, due to a labelling error.